Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP12168.RALzHix_EIgr_P0jvSNQcNFZfUynz0SHsb_azA6I3xXM8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP12168.RALzHix_EIgr_P0jvSNQcNFZfUynz0SHsb_azA6I3xXM8130_assertion type Assertion NP12168.RALzHix_EIgr_P0jvSNQcNFZfUynz0SHsb_azA6I3xXM8130_head.
- NP12168.RALzHix_EIgr_P0jvSNQcNFZfUynz0SHsb_azA6I3xXM8130_assertion description "[Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP12168.RALzHix_EIgr_P0jvSNQcNFZfUynz0SHsb_azA6I3xXM8130_provenance.
- NP12168.RALzHix_EIgr_P0jvSNQcNFZfUynz0SHsb_azA6I3xXM8130_assertion evidence source_evidence_curated NP12168.RALzHix_EIgr_P0jvSNQcNFZfUynz0SHsb_azA6I3xXM8130_provenance.
- NP12168.RALzHix_EIgr_P0jvSNQcNFZfUynz0SHsb_azA6I3xXM8130_assertion SIO_000772 20978260 NP12168.RALzHix_EIgr_P0jvSNQcNFZfUynz0SHsb_azA6I3xXM8130_provenance.
- NP12168.RALzHix_EIgr_P0jvSNQcNFZfUynz0SHsb_azA6I3xXM8130_assertion wasDerivedFrom ctd_human-20150221 NP12168.RALzHix_EIgr_P0jvSNQcNFZfUynz0SHsb_azA6I3xXM8130_provenance.
- NP12168.RALzHix_EIgr_P0jvSNQcNFZfUynz0SHsb_azA6I3xXM8130_assertion wasGeneratedBy ECO_0000218 NP12168.RALzHix_EIgr_P0jvSNQcNFZfUynz0SHsb_azA6I3xXM8130_provenance.